Switch to:

GuruFocus Financial Strength Rank measures how strong a company’s financial situation is. It is based on these factors

1. The debt burden that the company has as measured by its Interest coverage (current year).
2. Debt to revenue ratio. The lower, the better
3. Altman Z-score.

A company ranks high with financial strength is likely to withstand any business slowdowns and recessions.

Financial Strength : 8/10

vs
industry
vs
history
Cash to Debt 6.43
CERN's Cash to Debt is ranked higher than
60% of the 1672 Companies
in the Global Health Information Services industry.

( Industry Median: 22.71 vs. CERN: 6.43 )
CERN' s 10-Year Cash to Debt Range
Min: 0.5   Max: 6.43
Current: 6.43

0.5
6.43
Equity to Asset 0.78
CERN's Equity to Asset is ranked higher than
85% of the 1618 Companies
in the Global Health Information Services industry.

( Industry Median: 0.60 vs. CERN: 0.78 )
CERN' s 10-Year Equity to Asset Range
Min: 0.54   Max: 0.79
Current: 0.78

0.54
0.79
Interest Coverage 136.30
CERN's Interest Coverage is ranked higher than
60% of the 1026 Companies
in the Global Health Information Services industry.

( Industry Median: 690.23 vs. CERN: 136.30 )
CERN' s 10-Year Interest Coverage Range
Min: 1.09   Max: 136.3
Current: 136.3

1.09
136.3
F-Score: 7
Z-Score: 14.10
M-Score: -2.70
GuruFocus Profitability Rank ranks how profitable a company is and how likely the company’s business will stay that way. It is based on these factors:

1. Operating Margin
2. Trend of the Operating Margin (5-year average). The company with an uptrend profit margin has a higher rank.
••3. Consistency of the profitability
4. Piotroski F-Score
5. Predictability Rank•

The maximum rank is 10. A rank of 7 or higher means a higher profitability and may stay that way. A rank of 3 or lower indicates that the company has had trouble to make a profit.

Profitability Rank is not directly related to the Financial Strength Rank. But if a company is consistently profitable, its financial strength will be stronger.

Profitability & Growth : 9/10

vs
industry
vs
history
Operating margin (%) 19.79
CERN's Operating margin (%) is ranked higher than
92% of the 1586 Companies
in the Global Health Information Services industry.

( Industry Median: 5.71 vs. CERN: 19.79 )
CERN' s 10-Year Operating margin (%) Range
Min: -0.24   Max: 21.45
Current: 19.79

-0.24
21.45
Net-margin (%) 13.69
CERN's Net-margin (%) is ranked higher than
88% of the 1585 Companies
in the Global Health Information Services industry.

( Industry Median: 3.83 vs. CERN: 13.69 )
CERN' s 10-Year Net-margin (%) Range
Min: -7.81   Max: 27.85
Current: 13.69

-7.81
27.85
ROE (%) 12.58
CERN's ROE (%) is ranked higher than
82% of the 1548 Companies
in the Global Health Information Services industry.

( Industry Median: 6.84 vs. CERN: 12.58 )
CERN' s 10-Year ROE (%) Range
Min: -10.73   Max: 30.63
Current: 12.58

-10.73
30.63
ROA (%) 9.72
CERN's ROA (%) is ranked higher than
89% of the 1603 Companies
in the Global Health Information Services industry.

( Industry Median: 3.56 vs. CERN: 9.72 )
CERN' s 10-Year ROA (%) Range
Min: -5.95   Max: 17.08
Current: 9.72

-5.95
17.08
ROC (Joel Greenblatt) (%) 52.90
CERN's ROC (Joel Greenblatt) (%) is ranked higher than
76% of the 1584 Companies
in the Global Health Information Services industry.

( Industry Median: 34.63 vs. CERN: 52.90 )
CERN' s 10-Year ROC (Joel Greenblatt) (%) Range
Min: -0.5   Max: 71.2
Current: 52.9

-0.5
71.2
Revenue Growth (%) 15.10
CERN's Revenue Growth (%) is ranked higher than
85% of the 1368 Companies
in the Global Health Information Services industry.

( Industry Median: 6.20 vs. CERN: 15.10 )
CERN' s 10-Year Revenue Growth (%) Range
Min: 5.8   Max: 29.5
Current: 15.1

5.8
29.5
EBITDA Growth (%) 13.80
CERN's EBITDA Growth (%) is ranked higher than
77% of the 1102 Companies
in the Global Health Information Services industry.

( Industry Median: 7.70 vs. CERN: 13.80 )
CERN' s 10-Year EBITDA Growth (%) Range
Min: -12.1   Max: 71
Current: 13.8

-12.1
71
EPS Growth (%) 17.90
CERN's EPS Growth (%) is ranked higher than
80% of the 1059 Companies
in the Global Health Information Services industry.

( Industry Median: 7.50 vs. CERN: 17.90 )
CERN' s 10-Year EPS Growth (%) Range
Min: -26   Max: 83.4
Current: 17.9

-26
83.4
» CERN's 10-Y Financials

Financials


Revenue & Net Income
Cash & Debt
Oprt. Cash Flow & Free Cash Flow

» Details

Guru Trades

Q3 2013

CERN Guru Trades in Q3 2013

Murray Stahl 6,789 sh (New)
Vanguard Health Care Fund 10,765,200 sh (+100%)
PRIMECAP Management 21,000 sh (unchged)
Ron Baron 409,183 sh (-1.27%)
Manning & Napier Advisors, Inc 7,556,122 sh (-1.57%)
Frank Sands 18,080,498 sh (-11.62%)
Jeremy Grantham 163,934 sh (-11.93%)
RS Investment Management 57,646 sh (-13.5%)
Ray Dalio 9,336 sh (-49.55%)
Steven Cohen 7,868 sh (-92.7%)
» More
Q4 2013

CERN Guru Trades in Q4 2013

Jim Simons 82,904 sh (New)
Bill Frels 6,744 sh (New)
Ray Dalio 49,650 sh (+431.81%)
Steven Cohen 21,414 sh (+172.17%)
Murray Stahl 9,649 sh (+42.13%)
RS Investment Management 61,046 sh (+5.9%)
Ron Baron 409,888 sh (+0.17%)
Vanguard Health Care Fund 10,765,200 sh (unchged)
PRIMECAP Management 21,000 sh (unchged)
Frank Sands 17,871,178 sh (-1.16%)
Jeremy Grantham 154,927 sh (-5.49%)
Manning & Napier Advisors, Inc 6,955,224 sh (-7.95%)
» More
Q1 2014

CERN Guru Trades in Q1 2014

Jim Simons 171,600 sh (+106.99%)
Jeremy Grantham 282,878 sh (+82.59%)
Murray Stahl 13,586 sh (+40.8%)
RS Investment Management 77,846 sh (+27.52%)
Frank Sands 18,223,952 sh (+1.97%)
Ron Baron 412,562 sh (+0.65%)
Manning & Napier Advisors, Inc 6,979,741 sh (+0.35%)
Vanguard Health Care Fund 10,765,200 sh (unchged)
PRIMECAP Management 21,000 sh (unchged)
Bill Frels Sold Out
Ray Dalio 43,177 sh (-13.04%)
Steven Cohen 14,400 sh (-32.75%)
» More
Q2 2014

CERN Guru Trades in Q2 2014

Manning & Napier Advisors, Inc 11,792,338 sh (+68.95%)
» More
» Details

Insider Trades

Latest Guru Trades with CERN

GuruDate Trades Impact to Portfolio Price Range * (?) Current Price Change from Average Current Shares
Ray Dalio 2013-12-31 Add 431.81%0.02%$52.7 - $58.24 $ 54.09-4%49650
Vanguard Health Care Fund 2013-09-30 Add 100%0.95%$46.06 - $52.61 $ 54.0911%10765200
Frank Sands 2013-09-30 Reduce -11.62%0.38%$46.06 - $52.61 $ 54.0911%18080498
Ray Dalio 2013-09-30 Reduce -49.55%$46.06 - $52.61 $ 54.0911%9336
Vanguard Health Care Fund 2013-06-30 Reduce -50%1%$48.045 - $99.35 $ 54.09-43%5382600
Mariko Gordon 2013-06-30 Sold Out 0.13%$45.6 - $49.675 $ 54.0913%0
Frank Sands 2013-03-31 Add 7.35%0.23%$38.76 - $47.37 $ 54.0925%10063003
Ray Dalio 2013-03-31 New Buy0.01%$38.76 - $47.37 $ 54.0925%9100
Frank Sands 2012-12-31 Add 16.39%0.41%$34 - $40.56 $ 54.0941%9374174
Ron Baron 2012-12-31 Reduce -55.85%0.16%$34 - $40.56 $ 54.0941%260291
Frank Sands 2012-09-30 Add 73.19%1.1%$35.52 - $41.78 $ 54.0944%8054102
Meridian Funds 2012-09-30 Add 35.96%0.5%$35.52 - $41.78 $ 54.0944%692710
Frank Sands 2012-06-30 Add 17.78%0.26%$36.39 - $43.36 $ 54.0939%4650318
Ray Dalio 2012-06-30 Sold Out 0.0038%$36.39 - $43.36 $ 54.0939%0
PRIMECAP Management 2012-06-30 Reduce -74.07%$36.39 - $43.36 $ 54.0939%10500
Ray Dalio 2012-03-31 New Buy$29.89 - $39.07 $ 54.0969%3195
Ron Baron 2011-12-31 Add 28.18%0.05%$28.18 - $34.99 $ 54.0972%551088
Ron Baron 2011-09-30 Add 21.24%0.04%$27.47 - $36.44 $ 54.0969%429920
PRIMECAP Management 2011-09-30 Reduce -74.49%0.01%$27.47 - $36.44 $ 54.0969%50000
PRIMECAP Management 2011-06-30 Reduce -88.05%0.11%$27.23 - $31.05 $ 54.0985%196000
Premium More recent guru trades are included for Premium Members only!!
» Interactive Charts

Peter Lynch Chart ( What is Peter Lynch Charts )

Top Ranked Articles about Cerner Corp

Manning & Napier Report Top Five Holdings
Manning & Napier is an investment fund that provides investment solutions through various means such as managed accounts, mutual funds and collective investment trust funds. The fund was founded in 1970 and as of June 30, 2013, the fund managed $46.3 billion in client assets. Read more...

Ratios

vs
industry
vs
history
P/E(ttm) 46.70
CERN's P/E(ttm) is ranked higher than
69% of the 1820 Companies
in the Global Health Information Services industry.

( Industry Median: 50.50 vs. CERN: 46.70 )
CERN' s 10-Year P/E(ttm) Range
Min: 14.89   Max: 54.89
Current: 46.7

14.89
54.89
P/B 5.70
CERN's P/B is ranked higher than
54% of the 1820 Companies
in the Global Health Information Services industry.

( Industry Median: 3.00 vs. CERN: 5.70 )
CERN' s 10-Year P/B Range
Min: 2.05   Max: 6.74
Current: 5.7

2.05
6.74
P/S 6.32
CERN's P/S is ranked lower than
51% of the 1820 Companies
in the Global Health Information Services industry.

( Industry Median: 2.42 vs. CERN: 6.32 )
CERN' s 10-Year P/S Range
Min: 1.4   Max: 7.51
Current: 6.32

1.4
7.51
PFCF 450.80
CERN's PFCF is ranked higher than
68% of the 1820 Companies
in the Global Health Information Services industry.

( Industry Median: 146.80 vs. CERN: 450.80 )
CERN' s 10-Year PFCF Range
Min: 15.21   Max: 1431.3
Current: 450.8

15.21
1431.3
EV-to-EBIT 29.27
CERN's EV-to-EBIT is ranked higher than
70% of the 1820 Companies
in the Global Health Information Services industry.

( Industry Median: 33.52 vs. CERN: 29.27 )
CERN' s 10-Year EV-to-EBIT Range
Min: 9.4   Max: 36.6
Current: 29.27

9.4
36.6
PEG 3.20
CERN's PEG is ranked higher than
82% of the 1820 Companies
in the Global Health Information Services industry.

( Industry Median: 9999.00 vs. CERN: 3.20 )
CERN' s 10-Year PEG Range
Min: 0.82   Max: 3.7
Current: 3.2

0.82
3.7
Shiller P/E 59.30
CERN's Shiller P/E is ranked higher than
85% of the 1820 Companies
in the Global Health Information Services industry.

( Industry Median: 9999.00 vs. CERN: 59.30 )
CERN' s 10-Year Shiller P/E Range
Min: 25.06   Max: 87.66
Current: 59.3

25.06
87.66
Current Ratio 3.13
CERN's Current Ratio is ranked higher than
80% of the 1648 Companies
in the Global Health Information Services industry.

( Industry Median: 1.92 vs. CERN: 3.13 )
CERN' s 10-Year Current Ratio Range
Min: 1.79   Max: 5.87
Current: 3.13

1.79
5.87
Quick Ratio 3.08
CERN's Quick Ratio is ranked higher than
81% of the 1648 Companies
in the Global Health Information Services industry.

( Industry Median: 1.80 vs. CERN: 3.08 )
CERN' s 10-Year Quick Ratio Range
Min: 1.75   Max: 5.81
Current: 3.08

1.75
5.81

Valuation & Return

vs
industry
vs
history
Price/Net Cash 216.40
CERN's Price/Net Cash is ranked higher than
79% of the 1820 Companies
in the Global Health Information Services industry.

( Industry Median: 9999.00 vs. CERN: 216.40 )
CERN' s 10-Year Price/Net Cash Range
Min: 18.23   Max: 525.5
Current: 216.4

18.23
525.5
Price/Net Current Asset Value 35.60
CERN's Price/Net Current Asset Value is ranked higher than
77% of the 1820 Companies
in the Global Health Information Services industry.

( Industry Median: 9999.00 vs. CERN: 35.60 )
CERN' s 10-Year Price/Net Current Asset Value Range
Min: 4.44   Max: 1361.3
Current: 35.6

4.44
1361.3
Price/Tangible Book 7.60
CERN's Price/Tangible Book is ranked higher than
64% of the 1820 Companies
in the Global Health Information Services industry.

( Industry Median: 7.79 vs. CERN: 7.60 )
CERN' s 10-Year Price/Tangible Book Range
Min: 0.97   Max: 9.57
Current: 7.6

0.97
9.57
Price/DCF (Projected) 3.20
CERN's Price/DCF (Projected) is ranked higher than
80% of the 1820 Companies
in the Global Health Information Services industry.

( Industry Median: 9999.00 vs. CERN: 3.20 )
CERN' s 10-Year Price/DCF (Projected) Range
Min: 1.33   Max: 4.7
Current: 3.2

1.33
4.7
Price/Median PS Value 2.00
CERN's Price/Median PS Value is ranked higher than
52% of the 1820 Companies
in the Global Health Information Services industry.

( Industry Median: 1.20 vs. CERN: 2.00 )
CERN' s 10-Year Price/Median PS Value Range
Min: 0.34   Max: 2.12
Current: 2

0.34
2.12
Price/Peter Lynch Fair Value 3.20
CERN's Price/Peter Lynch Fair Value is ranked higher than
89% of the 1820 Companies
in the Global Health Information Services industry.

( Industry Median: 9999.00 vs. CERN: 3.20 )
CERN' s 10-Year Price/Peter Lynch Fair Value Range
Min: 0.45   Max: 3.32
Current: 3.2

0.45
3.32
Price/Graham Number 3.90
CERN's Price/Graham Number is ranked higher than
73% of the 1820 Companies
in the Global Health Information Services industry.

( Industry Median: 11.00 vs. CERN: 3.90 )
CERN' s 10-Year Price/Graham Number Range
Min: 1.37   Max: 9.11
Current: 3.9

1.37
9.11
Earnings Yield (Greenblatt) 3.40
CERN's Earnings Yield (Greenblatt) is ranked higher than
56% of the 1384 Companies
in the Global Health Information Services industry.

( Industry Median: 5.60 vs. CERN: 3.40 )
CERN' s 10-Year Earnings Yield (Greenblatt) Range
Min: 2.7   Max: 10.6
Current: 3.4

2.7
10.6
Forward Rate of Return (Yacktman) 15.97
CERN's Forward Rate of Return (Yacktman) is ranked higher than
84% of the 1188 Companies
in the Global Health Information Services industry.

( Industry Median: 5.80 vs. CERN: 15.97 )
CERN' s 10-Year Forward Rate of Return (Yacktman) Range
Min: 0.6   Max: 22.6
Current: 15.97

0.6
22.6

Business Description

Industry: Application Software » Health Information Services
Compare:CTRX, ATHN, MDRX, AH, QSII » details
Traded in other countries:CRE.Germany
Cerner Corporation is a Delaware corporation organized in 1986. The Company is a supplier of health care information technology (HCIT) solutions, services, devices and hardware. Its solutions optimize processes and help eliminate errors, variance and waste for health care organizations ranging from single-doctor practices to entire countries, for the pharmaceutical and medical device industries, and for the field of health care as a whole. These solutions are licensed by approximately 10,000 facilities around the world, including more than 2,700 hospitals; 4,150 physician practices; 45,000 physicians; 550 ambulatory facilities, such as laboratories, ambulatory centers, behavioral health centers, cardiac facilities, radiology clinics and surgery centers; 800 home health facilities; 45 employer sites and 1,750 retail pharmacies. The Company designs and develops its software solutions on the unified Cerner Millennium architecture, a person-centric computing framework, which combines clinical, financial and management information systems. This architecture allows providers to securely access an individual's electronic health record (EHR) at the point of care, and it organizes and proactively delivers information to meet the specific needs of physicians, nurses, laboratory technicians, pharmacists, front- and back-office professionals and consumers. The Company offers a range of services, including implementation and training, remote hosting, operational management services, revenue cycle services, support and maintenance, health care data analysis, clinical process optimization, transaction processing, employer health centers, employee wellness programs and third party administrator (TPA) services for employer-based health plans. In addition to software and services, it offers a range of complementary hardware and devices, both directly from Cerner and as a reseller for third parties. The Company's main competitors in the health care solutions and services market includes: Allscripts Healthcare Solutions, Inc., Computer Programs and Systems, Inc. (CPSI), Epic Systems Corporation (Epic), GE Healthcare Technologies (GE), Healthcare Management Systems, Inc. (HMS), Healthland, Inc., Computer Sciences Corporation (iSoft), Keane, Inc., McKesson Corporation (McKesson), Medical Information Technology, Inc. (Meditech), Siemens Medical Solutions Health Services Corporation (Siemens), and Quadramed Corporation (Quadramed), each of which offers a suite of software solutions that compete with many of its software solutions and services.
» More Articles for CERN

Headlines

Articles On GuruFocus.com
Manning & Napier Report Top Five Holdings Jul 18 2014 
Weekly 52-Week Highs Highlight: PCLN, NFLX, CERN, HPQ Feb 17 2014 
Weekly CFO Sells Highlight: FB, ZNGA, TRLA, EQT, CERN Aug 06 2013 
This Is What Real Bubbles Look Like May 29 2013 
comment on CERN Feb 18 2013 
4 Big Cap Stocks That Are Thriving Oct 31 2012 
Weekly Top Insider Sells: GMCR, VRTX, CERN, and AGN May 14 2012 
HealthStream: A Solid Long-Term Play Apr 19 2012 
Weekly Top Insider Sells: CVS, DELL, CERN, FIS, and CXO Mar 19 2012 
Strong S Feb 04 2012 


More From Other Websites
Watch Out: Barbarians At The Gate For Cerner (CERN) Jul 15 2014
3 Stocks Driving The Computer Software & Services Industry Higher Jul 15 2014
Cerner to Release Second Quarter 2014 Earnings Results July 24 Jul 07 2014
Cerner to Release Second Quarter 2014 Earnings Results July 24 Jul 07 2014
Midday movers: Lorillard, PetSmart, Walgreen & More Jul 03 2014
Cerner ACE awards recognize excellence inadopting health care IT in canada Jul 02 2014
Cerner ACE Awards Recognize Excellence in Adopting Health Care IT in Canada Jul 02 2014
Coverage initiated on Cerner by Topeka Capital Markets Jun 27 2014
Cerner Enters New Agreement with North Carolina's Mission Health Jun 25 2014
Newly Enhanced Relationship Between Mission Health and Cerner to Boost Healthcare Innovation Jun 24 2014
Cerner Enters UAE's Health Care Industry Jun 10 2014
Mobile Doctors Partners With Cerner to Empower Communities to Manage Their Health Jun 09 2014
Cerner management to meet with Stephens May 29 2014
CERNER CORP /MO/ Files SEC form 8-K, Submission of Matters to a Vote of Security Holders, Other... May 27 2014
Cerner announces amendment to share repurchase program May 27 2014
Cerner Announces Amendment to Share Repurchase Program May 27 2014
Startup pitches snoop-proof (even NSA-proof) email May 16 2014
Wall Street Transcript Interview with Justin C. Dearborn, the CEO and President of Merge Healthcare... May 16 2014
Cerner to Hold 2014 Shareholders Meeting May 23 May 16 2014
CERNER CORP /MO/ Financials May 02 2014

Personalized Checklist








Within your circle of competence?
Macro economic environment favorable?
High quality business?
Enough margin of safety with stocks?
Gurus are buying?
Insiders are buying?
Management capable and shareholder friendly?
Catalyst for stock price to appreciate?
Your level of confidence with the research?

Add Notes, Comments or Ask Questions

User Comments

No comment yet

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
Free 7-day Trial
FEEDBACK
Email Hide